FFCP PHASE1:Mm9::chr17:10914421..10914424,-: Difference between revisions
From FANTOM5_SSTAR
No edit summary |
No edit summary |
||
Line 1: | Line 1: | ||
{{FFCP|EntrezGene=NA|HGNC=|MCL_coexpression_id=92|UniProt=NA|association_with_transcript=NA|description=CAGE_peak_at_chr17:10914421..10914424,-|id=chr17:10914421..10914424,-|ontology_enrichment_celltype=CL:0000325!1.68e-58!2;CL:0000217!1.68e-58!2;CL:0000328!1.68e-58!2;CL:0002573!1.68e-58!2;CL:0002376!1.68e-58!2;CL:0000218!1.68e-58!2;CL:0000692!1.68e-58!2;CL:0002377!1.68e-58!2;CL:0002375!1.68e-58!2;CL:0000215!1.70e-39!3;CL:0000630!1.70e-39!3;CL:0000333!9.45e-13!10;CL:0000095!9.45e-13!10;CL:0000243!9.45e-13!10;CL:0000123!9.45e-13!10;CL:0000125!9.45e-13!10;CL:0000030!9.45e-13!10;CL:0000339!9.45e-13!10|ontology_enrichment_celltype_v019_2=CL:0000217,4.52e-44,2;CL:0000328,4.52e-44,2;CL:0002573,4.52e-44,2;CL:0002376,4.52e-44,2;CL:0000218,4.52e-44,2;CL:0000692,4.52e-44,2;CL:0002377,4.52e-44,2;CL:0002375,4.52e-44,2;CL:0000215,5.61e-30,3;CL:0000333,4.12e-10,10;CL:0000095,4.12e-10,10;CL:0000243,4.12e-10,10;CL:0000123,4.12e-10,10;CL:0000125,4.12e-10,10;CL:0000030,4.12e-10,10;CL:0000339,4.12e-10,10|ontology_enrichment_disease=|ontology_enrichment_disease_v019_2=|ontology_enrichment_uberon=UBERON:0000010!1.07e-11!11|ontology_enrichment_uberon_v019_2=UBERON:0000010,2.51e-09,11|phase1_expression=0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1.06016670666458,0.151143120213571,0,0,0,0,0,0,0.140444420131752,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0|short_description=p@chr17:10914421..10914424,-}} | {{FFCP | ||
|DHSsupport=NA | |||
|DPIdataset=NA | |||
|EntrezGene=NA | |||
|HGNC= | |||
|MCL_coexpression_id=92 | |||
|TSSclassifier=NA | |||
|UniProt=NA | |||
|association_with_transcript=NA | |||
|cluster_id=chr17:10914421..10914424,- | |||
|description=CAGE_peak_at_chr17:10914421..10914424,- | |||
|id=chr17:10914421..10914424,- | |||
|ontology_enrichment_celltype=CL:0000325!1.68e-58!2;CL:0000217!1.68e-58!2;CL:0000328!1.68e-58!2;CL:0002573!1.68e-58!2;CL:0002376!1.68e-58!2;CL:0000218!1.68e-58!2;CL:0000692!1.68e-58!2;CL:0002377!1.68e-58!2;CL:0002375!1.68e-58!2;CL:0000215!1.70e-39!3;CL:0000630!1.70e-39!3;CL:0000333!9.45e-13!10;CL:0000095!9.45e-13!10;CL:0000243!9.45e-13!10;CL:0000123!9.45e-13!10;CL:0000125!9.45e-13!10;CL:0000030!9.45e-13!10;CL:0000339!9.45e-13!10 | |||
|ontology_enrichment_celltype_v019_2=CL:0000217,4.52e-44,2;CL:0000328,4.52e-44,2;CL:0002573,4.52e-44,2;CL:0002376,4.52e-44,2;CL:0000218,4.52e-44,2;CL:0000692,4.52e-44,2;CL:0002377,4.52e-44,2;CL:0002375,4.52e-44,2;CL:0000215,5.61e-30,3;CL:0000333,4.12e-10,10;CL:0000095,4.12e-10,10;CL:0000243,4.12e-10,10;CL:0000123,4.12e-10,10;CL:0000125,4.12e-10,10;CL:0000030,4.12e-10,10;CL:0000339,4.12e-10,10 | |||
|ontology_enrichment_disease= | |||
|ontology_enrichment_disease_v019_2= | |||
|ontology_enrichment_uberon=UBERON:0000010!1.07e-11!11 | |||
|ontology_enrichment_uberon_v019_2=UBERON:0000010,2.51e-09,11 | |||
|phase1_expression=0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1.06016670666458,0.151143120213571,0,0,0,0,0,0,0.140444420131752,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0 | |||
|short_description=p@chr17:10914421..10914424,- | |||
}} |
Latest revision as of 07:18, 4 August 2015
Short description: | p@chr17:10914421..10914424, - |
---|---|
Species: | Mouse (Mus musculus) |
DPI dataset: | NA |
TSS-like-by-RIKEN-classifier(Yes/No): | NA |
DHS support(Yes/No): | NA |
Description: | CAGE_peak_at_chr17:10914421..10914424, - |
Coexpression cluster: | MCL_coexpression_mm9:92 |
Association with transcript: | NA |
EntrezGene: | NA |
Link to Zenbu: | ZENBU |
View on UCSC genome browser
CAGE Expression
- Click each plot point to find sample in table
Ontology-based sample term enrichment analysis<b>Summary:</b>This analysis has been performed by utilizing wilcoxon rank sum test.When the number of associated cells/tissues are > n , randomly sampled n cells/tissues are used for P value calculation with rank sum test. this process are repeated several times, and the P values are averaged on the log space <br><b>Analyst:</b> Hideya Kawaji<br><br>link to source dataset<br>data
Ontology term | p-value | n |
---|---|---|
insulating cell | 4.52e-44 | 2 |
myelin accumulating cell | 4.52e-44 | 2 |
Schwann cell | 4.52e-44 | 2 |
non-myelinating Schwann cell | 4.52e-44 | 2 |
myelinating Schwann cell;;Schwann cell | 4.52e-44 | 2 |
terminal Schwann cell | 4.52e-44 | 2 |
immature Schwann cell | 4.52e-44 | 2 |
Schwann cell precursor | 4.52e-44 | 2 |
barrier cell | 5.61e-30 | 3 |
migratory neural crest cell | 4.12e-10 | 10 |
neuron associated cell | 4.12e-10 | 10 |
glial cell (sensu Vertebrata) | 4.12e-10 | 10 |
neuron associated cell (sensu Vertebrata) | 4.12e-10 | 10 |
glial cell | 4.12e-10 | 10 |
glioblast | 4.12e-10 | 10 |
glioblast (sensu Vertebrata) | 4.12e-10 | 10 |
Ontology term | p-value | n |
---|---|---|
peripheral nervous system | 2.51e-09 | 11 |